GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (WBO:ABC) » Definitions » Research & Development

Cencora (WBO:ABC) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cencora Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cencora's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Cencora Research & Development Historical Data

The historical data trend for Cencora's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Research & Development Chart

Cencora Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cencora Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cencora Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora  (WBO:ABC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cencora Research & Development Related Terms

Thank you for viewing the detailed overview of Cencora's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora (WBO:ABC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (WBO:ABC) » Definitions » Research & Development
Comparable Companies
CAH MCK HSIC PDCO OMI ZYXI EDAP AHG YI COSM HKSE:01099 SHSE:601607 MIL:AMP NZSE:EBO XSWX:GALE SHSE:600511 TSE:7459 SZSE:000028 TSE:2784 TSE:9987
Traded in Other Exchanges
COR:USA ABG:Germany C1CO34:Brazil
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Website
https://www.cencora.com
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (WBO:ABC) Headlines

No Headlines